Brilinta

Brilinta (ticagrelor) is a prescription medication used to treat Acute coronary syndrome, heart attack prevention. A widely advertised blood thinner taken after a heart attack or stent to lower the risk of another cardiovascular event.

Blocks the P2Y12 receptor on platelets so they are less likely to clump together and form dangerous clots.

Commonly reported side effects of Brilinta include Bleeding, Shortness of breath, Bruising, Headache, and Dizziness. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Brilinta carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Brilinta is ticagrelor, which belongs to a class of medicines known as P2Y12 Platelet Inhibitor (Antiplatelet).

Brilinta is manufactured by AstraZeneca. It was first approved in 2011.

You may be able to lower the cost of Brilinta by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.